27 May 2022
Duke Royalty Limited
("Duke Royalty", "Duke" or the "Company")
Director / PCA Dealings
Further to its announcement on 10 May 2022, and following admission of the Placing Shares to trading on AIM this morning, the Company announces that the following Directors and/or their persons closely associated ("PCAs") have acquired Placing Shares at the Issue Price:
| Director/PCA | Number of Placing Shares subscribed |
| Abinvest Corporation* | 250,000 |
| Nigel Birrell (Chairman) | 250,000 |
| Arlington Partners Fund** | 1,000,000 |
*Abinvest Corporation is a wholly owned subsidiary of Abingdon Capital Corporation, which is controlled by Neil Johnson, Chief Executive Officer
**Arlington Partners Fund is owned by Arlington Group Asset Management Limited, in which Charlie Cannon Brookes, Executive Director, has a 50 per cent. interest.
Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Company's announcement released via RNS at 4.44pm on 10 May 2022.
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Abinvest Corporation | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status | PCA of Neil Johnson, Chief Executive Officer of Duke Royalty Limited | ||||
| b)
| Initial notification /Amendment | Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Duke Royalty Limited | ||||
| b)
| LEI | 213800GUTKPSJ39SER44 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of nil par value
ISIN: GG00BYZSSY63 | ||||
| b)
| Nature of the transaction | Acquisition of shares pursuant to placing | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information - Aggregated volume - Price | N/A | ||||
| e)
| Date of the transaction
| 27 May 2022 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Nigel Birrell | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status | Chairman | ||||
| b)
| Initial notification /Amendment | Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Duke Royalty Limited | ||||
| b)
| LEI | 213800GUTKPSJ39SER44 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of nil par value
ISIN: GG00BYZSSY63 | ||||
| b)
| Nature of the transaction | Acquisition of shares pursuant to placing | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information - Aggregated volume - Price | N/A | ||||
| e)
| Date of the transaction
| 27 May 2022 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Arlington Partners Fund | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status | PCA of Charlie Cannon Brookes, Executive Director of Duke Royalty Limited | ||||
| b)
| Initial notification /Amendment | Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Duke Royalty Limited | ||||
| b)
| LEI | 213800GUTKPSJ39SER44 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of nil par value
ISIN: GG00BYZSSY63 | ||||
| b)
| Nature of the transaction | Acquisition of shares pursuant to placing | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information - Aggregated volume - Price | N/A | ||||
| e)
| Date of the transaction
| 27 May 2022 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
For further information, please visit www.dukeroyalty.com or contact:
| Duke Royalty Limited | Neil Johnson / Charlie Cannon Brookes / Hugo Evans
| +44 (0) 1481 741 240 |
| Cenkos Securities plc (Nominated Adviser and Joint Broker) | Stephen Keys / Callum Davidson / Dan Hodkinson / Julian Morse / Michael Johnson | +44 (0) 207 397 8900
|
| | | |
| Canaccord Genuity (Joint Broker)
| Adam James / Sam Lucas / Georgina McCooke | +44 (0) 207 523 8000 |
| SEC Newgate (PR) | Elisabeth Cowell/ Richard Bicknell | +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk |
About Duke Royalty
Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
